Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. ANI Pharmaceuticals Inc shares valued at $1,941,442 were sold by Lalwani Nikhil on Nov 26 ’24. At $57.99 per share, Lalwani Nikhil sold 33,481 shares. The insider’s holdings dropped to 370,378 shares worth approximately $22.0 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Lalwani Nikhil purchased 33,481 shares, netting a total of over 1,941,484 in proceeds.
Before that, Mutz Christopher had sold 6,500 shares from its account. In a trade valued at $375,050, the HEAD OF RARE DISEASE traded ANI Pharmaceuticals Inc shares for $57.70 each. Upon closing the transaction, the insider’s holdings decreased to 6,500 shares, worth approximately $4.56 million.
As published in their initiating research note from Piper Sandler on October 11, 2024, ANI Pharmaceuticals Inc [ANIP] has been an Overweight and the price target has been revised to $68. Analysts at CapitalOne started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid March. As of August 22, 2023, H.C. Wainwright has reiterated its “Buy” rating for ANIP. Earlier on March 01, 2023, Guggenheim initiated its rating. Their recommendation was “a Buy” for ANIP stock.
Analyzing ANIP Stock Performance
During the last five days, there has been a surge of approximately 7.79%. Over the course of the year, ANI Pharmaceuticals Inc shares have jumped approximately 7.71%. Shares of the company reached a 52-week high of $70.81 on 03/25/24 and a 52-week low of $52.53 on 09/11/24. A 50-day SMA is recorded $58.29, while a 200-day SMA reached $62.21. Nevertheless, trading volume fell to 0.23 million shares from 0.36 million shares the previous day.
Support And Resistance Levels for ANI Pharmaceuticals Inc (ANIP)
According to the 24-hour chart, there is a support level at 58.07, which, if violated, would cause prices to drop to 56.76. In the upper region, resistance lies at 60.13. The next price resistance is at 60.88. RSI (Relative Strength Index) is 54.70 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.47, which suggests the price will decrease in the coming days. Percent R is at 41.29%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of ANI Pharmaceuticals Inc (ANIP)?
On September 07, 2022, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $50.
